Editas Medicine Inc (EDIT) Directors and Executive Officers - CSIMarket
CSIMarket
 
Editas Medicine Inc   (NASDAQ: EDIT)

Editas Medicine Inc

Officers & Directors


Andrew Hirsch
Director

Gilmore O Neill
Principal Executive Officer
President and Chief Executive Officer
Director

Erick Lucera
Chief Financial Officer (principal financial and accounting officer)

Meeta Chatterjee
Director

Bernadette Connaughton
Director

Elliott Levy
Director

David Scadden
Director

Jessica Hopfield
Director

Akshay K. Vaishnaw
Director

Emma Reeve
Chair of the Board ,

Editas Medicine Inc currently has 87 employees.

  News about Editas Medicine Inc Key Personnel

Editas Medicine: Balancing the Future of Gene Editing with Strategic Financial Maneuvers Amidst Industry Challenges,

Editas Medicine: Navigating Financial Challenges while Pioneering Gene Editing SolutionsIn an ever-evolving biotechnology landscape, Editas Medicine Inc. is making strides both in clinical advancements and financial strategy. The company recently announced significant progress towards its 2024 goals, revealing pivotal developments in its quest to treat genetic disorders such as sickle cell disease and beta thalassemia. This article will outline the key facts from their recent press releases and financial performance metrics to provide a comprehensive overview of Editas Medicine s current position. Progress in Gene EditingEditas Medicine has achieved a critical milestone by obtaining in vivo preclinical proo...






EDIT Management Effectiveness EDIT Revenue per Employee EDIT Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.